Johansson, Hanna K.L.Damdimopoulou, Pauliinavan Duursen, Majorie B.M.Boberg, JulieFranssen, Delphinede Cock, MarijkeJääger, KerstiWagner, MagdalenaVelthut-Meikas, AgneXie, YulingConnolly, LisaLelandais, PaulineMazaud Guittot, SéverineSalumets, AndresDraskau, Monica KamFilis, PanagiotisFowler , Paul A.Christiansen, SofeParent, Anne-SimoneSvingen, Terje2020-07-212020-07-212020-10Johansson, H K L, Damdimopoulou, P, van Duursen, M B M, Boberg, J, Franssen, D, de Cock, M, Jääger, K, Wagner, M, Velthut-Meikas, A, Xie, Y, Connolly, L, Lelandais, P, Mazaud Guittot, S, Salumets, A, Draskau, M K, Filis, P, Fowler , P A, Christiansen, S, Parent, A-S & Svingen, T 2020, 'Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals', Archives of Toxicology, vol. 94, no. 10, pp. 3359-3379. https://doi.org/10.1007/s00204-020-02834-y0340-5761ORCID: /0000-0002-4831-9075/work/94084031https://hdl.handle.net/2164/14750Funding This work was funded by the EU Horizon 2020 project FREIA (Grant Number 825100).21948196engovaryreproductionAdverse outcome pathwayAOPOvarian dysgenesis syndromeODSEndocrine disrupting chemicalsEDCOvaryReproductionEndocrine-disrupting chemicalsR Medicine (General)Health, Toxicology and MutagenesisToxicologyEuropean Commission825100R1Journal item10.1007/s00204-020-02834-yhttp://www.scopus.com/inward/record.url?scp=85087607880&partnerID=8YFLogxK9410